Current EU-Projects
EU - Horizon Europe
Projects coordinated by MUI
NR2F6-AIM - NR2F6 Blockade as Adoptive Immune Cell Therapy for Metastatic Melanoma
Coordinator: Univ.-Prof. Dr. Gottfried Baier
Duration: 01.10.2024 - 31.03.2026
EU - Horizon Europe
Projects with participation of MUI
T-RAFIC
Training network for tracking and controlling therapeutic immune cells in cancer
Partner: Univ.-Prof. Dr. Patricia Stoitzner
SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension
Partner: Assistenzprofessor Priv.-Doz. Dr. Sebastian Reinstadler
Duration: 01.01.2025 - 30.06.2032
PredictAYA
Prediction and prevention of late effects in AYA cancer survivors – An effort to understand, predict and prevent late effects in AYAs 15-39 years of age, with a focus on infertility and reproductive health
Partner: Priv.-Doz. Dr. Bettina Böttcher
PARC
Partnership for the assessment of risks from chemicals
Partner: Univ.-Prof. Mag. Dr. Herbert Oberacher, Ass.-Prof.in Priv.-Doz.in Dr.in Johanna Gostner, Dipl.-Ing. Dr. Martin Paparella, MAS
Duration: 01.05.2022 - 30.04.2029
EUonQoL
Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe
Partner: Univ.-Prof. Dr. Bernhard Holzner
Duration: 01.01.2023 - 31.12.2026
ProBLeMS
Development and Implementation of Metacognitive Problem-Based Modules in Blended Learning Courses in Medical Sciences
Partner: DDr. Sasa Rajsic
Duration: 01.04.2023 - 31.03.2026
EBRAINS 2.0
EBRAINS 2.0: A Research Infrastructure to Advance Neuroscience and Brain Health
Partner: Ass.-Prof. Johannes Passecker, PhD
Duration: 01.01.2024 - 30.12.2026
Insight
Integrated Models for the Development and Assessment of High Impact Chemicals and Material
Partner: Dipl.-Ing. Dr. Martin Paparella, MAS
Duration: 01.01.2024 - 31.12.2027
CHIASMA
Accessible Innovative Methods for the Safety & Sustainability Assessment of Chemicals & Materials
Partner: Dipl.-Ing. Dr. Martin Paparella, MAS
Duration: 01.01.2024 - 31.12.2027
MONALISA
A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis
Partner: Priv.-Doz. Mag. David Riedl, PhD
Duration: 01.01.2024 - 31.05.2026
EU-WISH
EU Wastewater Integrated Surveillance for Public Health
Partner: Univ.-Prof. Dr. Herbert Oberacher
Duration: 01.11.2023 - 31.10.2026
Marie Skłodowska-Curie Actions - MSCA
GRASP-SYNERGY
Developments of the Generalized Retrieval of Atmospheric and Surface Properties for the synergy of different satellites and ground-based networks: Advances in atmosphere and surface characterizations
Partner: Dr. Axel Kreuter, MSc, Institute for Biomedical Physics
Duration: 01.12.2023 - 30.11.2027
PROMOTE
PRostate cancer OMics Oriented InTErvention
Partner: Univ.-Prof. Dr. Zoran Culig, University Hospital for Urology
Duration: 01.09.2024 - 31.08.2028
EU - Horizon - ERC-2021
Projects coordinated by MUI
MEGI CD
MEtabolic Gut Inflammation in Crohn's Disease
Coordinator: Assistenzprofessor Dr. Timon Adolph PhD, University Hospital for Internal Medicine I
Duration: 01.04.2022 - 31.03.2027
Projects in Horizon 2020
Projects with participation of MUI
Alternative
environmentAL Toxicity chEmical mixtuRes through aN innovative platform based on aged cardiac tissue model
Partner: Dipl.-Ing. Dr. Martin Paparella, Institute of Medical Biochemistry
Duration: 01.10.2021 - 31.03.2025
ATMO ACCESS
Solutions for Sustainable Access to Atmospheric Research Facilities
Partner: Dr. Jochen Wagner, Institute of Biomedical Physics
Duration: 01.04.2021 – 31.03.2025
INCITE
Immune Niches for Cancer ImmonoTherapy Enhancement
Partner: Univ.-Prof. Dipl.-Ing. Dr. Zlatko Trajanoski, Institute of Bioinformatics
Duration: 01.05.2021 – 30.04.2025
PRISMAP
The European medical isotope programme: Production of high purity isotopes by mass separation
Partner: Univ.-Doz. Mag. Dr. Clemens Decristoforo, University Hospital for Nuclear Medicine
Duration: 01.05.2021 – 30.04.2025
SAND
Secretion, Autophagy and their role in Neurodegeneration
Partner: Univ.-Prof. Dr. Farhan Hesso, Institute of Pathophysiology
Duration: 01.01.2021 – 31.10.2024
TTV GUIDE TX
Personalisation of immunosuppression by monitoring viral load post kidney transplantation – a randomized controlled phase II trial
Partner: Assoz. Prof. Priv.-Doz. Dr. Hannes Neuwirt, University Hospital for Internal Medicine IV
Duration: 01.05.2021 – 30.04.2026
Marie Skłodowska-Curie Research and Innovation Staff Exchange
OCSEAN
OCeanic and South East Asian Navigators
Partner: ao. Univ.-Prof. Dr. Walther Parson, Institute of Forensic Medicine
Duration: 01.01.2020 – 31.12.2025
Projects in FP7
Large-scale integrating projects
Small or medium-scale focused research project
Projects coordinated by MUI
imSAVAR
Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
Partner: Univ.-Prof. Dipl.-Ing. Dr. Zlatko Trajanoski, Institute of Bioinformatics
Duration: 01.12.2019 – 30.11.2025
IDEA-FAST
Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivitiesdaily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases
Partner: Univ.-Prof. Dr. Klaus Seppi, University Hospital for Neurology
Duration: 01.11.2019 – 30.04.2026
SISAQOL
Setting International Standards of Patient-Reported Outcomes and Quality of Life Endpoints Data in Cancer Clinical Trials
Partner: Univ.-Prof. Dr. Bernhard Holzner, Priv.-Doz. Dr. Johannes Giesinger, University Hospital for Psychiatry II
Duration: 01.01.2021 – 31.12.2025
FWF-EU
ERA; PERMED 2021
BRAVA - Behaviours in REM sleep: personalised Automatic 3D Video Analysis as novel tool to detect alpha-synucleinopathies
Coordinator: Univ.-Prof. Dr Birgit Högl, University Hospital for Neurology
Duration: 01.04.2022 - 31.03.2026
ERA; PERMED 2022
Multi-omics Signatur der Nierenfibrose bei CKD (KindeySign)
Coordinator: Dr. Sara Denicolo
Duration: 02.05.2023 - 02.05.2026
SIGNAL - Proteomische Signaturen für personalisierte Intervention
Coordinator Univ.-Prof. Dr. Gert Mayer
Duration: 02.05.2023 - 01.05.2026
EU-Projects finished
aktualisiert 21.01.2025